PDT Partners LLC purchased a new position in Waters Corporation (NYSE:WAT - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 6,503 shares of the medical instruments supplier's stock, valued at approximately $2,397,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Lederer & Associates Investment Counsel CA boosted its position in shares of Waters by 1.0% in the 1st quarter. Lederer & Associates Investment Counsel CA now owns 3,155 shares of the medical instruments supplier's stock worth $1,163,000 after purchasing an additional 30 shares during the last quarter. FourThought Financial Partners LLC increased its stake in Waters by 5.1% in the first quarter. FourThought Financial Partners LLC now owns 658 shares of the medical instruments supplier's stock valued at $243,000 after purchasing an additional 32 shares in the last quarter. Benjamin Edwards Inc. increased its stake in Waters by 4.8% in the fourth quarter. Benjamin Edwards Inc. now owns 744 shares of the medical instruments supplier's stock valued at $276,000 after purchasing an additional 34 shares in the last quarter. Lido Advisors LLC increased its stake in Waters by 2.2% in the fourth quarter. Lido Advisors LLC now owns 1,734 shares of the medical instruments supplier's stock valued at $643,000 after purchasing an additional 38 shares in the last quarter. Finally, MainStreet Investment Advisors LLC increased its stake in Waters by 1.2% in the fourth quarter. MainStreet Investment Advisors LLC now owns 3,381 shares of the medical instruments supplier's stock valued at $1,254,000 after purchasing an additional 40 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities research analysts have commented on the stock. Wells Fargo & Company lowered their target price on shares of Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a research note on Tuesday, August 5th. Bank of America upped their target price on shares of Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Wall Street Zen downgraded shares of Waters from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th. Robert W. Baird lowered their target price on shares of Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Finally, Jefferies Financial Group set a $385.00 target price on shares of Waters and gave the company a "buy" rating in a research note on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $378.73.
Get Our Latest Stock Analysis on Waters
Waters Stock Up 2.2%
Waters stock traded up $6.59 during mid-day trading on Friday, reaching $306.28. The company's stock had a trading volume of 504,612 shares, compared to its average volume of 559,928. The company has a market capitalization of $18.23 billion, a price-to-earnings ratio of 27.62, a price-to-earnings-growth ratio of 2.79 and a beta of 1.07. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The business's 50 day simple moving average is $304.79 and its 200 day simple moving average is $336.08. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75.
Waters (NYSE:WAT - Get Free Report) last released its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. The business had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. Waters had a net margin of 21.71% and a return on equity of 38.60%. The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter last year, the firm earned $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, research analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current year.
About Waters
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
See Also
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
